ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 4.300
+0.010 (0.23%)
May 7, 2026, 4:08 PM HKT
-35.14% (1Y)
| Market Cap | 1.85B -12.9% |
| Revenue (ttm) | 171.70M +94.0% |
| Net Income | -243.24M |
| EPS | -0.59 |
| Shares Out | 431.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,483,200 |
| Average Volume | 1,595,000 |
| Open | 4.420 |
| Previous Close | 4.290 |
| Day's Range | 4.240 - 4.570 |
| 52-Week Range | 3.430 - 16.800 |
| Beta | 0.41 |
| RSI | 38.04 |
| Earnings Date | May 26, 2026 |